-
News | 2019.06.14
Ceremony for the 2019 Pasteur Vallery-Radot Prize (awarded by the BnF)
The National Library of France (BnF) has awarded the 2019 Pasteur Vallery-Radot Prize to Institut Pasteur scientists Guillaume Duménil and Rogerio Amino. The winners were invited by BnF President Laurence Engel to receive their awards on June 13, 2019, at a ceremony held in the BnF Richelieu Library and attended by Daniel Louvard, a member of the French Academy of Sciences, and Stewart Cole,...
-
Fiche maladie | 2019.06.25
HTLV-I
HTLV-1 was the first human retrovirus to be discovered – it was isolated in 1980 by Robert Gallo's team in the United States. In 5% of cases, infected individuals go on to develop leukemia or a myeloneuropathy. Ten to twenty million people are infected by the virus worldwide. The major areas of endemic HTLV-1 infection are south-west Japan, the Caribbean, Latin America and tropical Africa.
-
Article | 2019.10.21
Bordet Class (2019-2022)
Ph.D. StudentUndergraduate StudiesLaboratoryThesis AdvisorLab HeadDoctoral SchoolPh.D. ProjectPPU - studentsAICHER, Sophie-MarieImperial College London, London, United Kingdom Viral Genomics and vaccinationNolwenn JouvenetFrédéric TangyBioSPC ED 562 Human and avian antiviral response to zoonotic RNA virusesCOSTREIE, Maria-MirunaUniversity of Glasgow, Glasgow, ScotlandDynamic...
-
Article | 2020.03.16
Coronavirus: all COVID-19 news from the Institut Pasteur
On January 9, 2020, Chinese health authorities and the World Health Organization (WHO) officially announced the discovery of a novel coronavirus (first named 2019-nCoV, then officially SARS-CoV-2). This new virus is the pathogen responsible for the infectious respiratory disease called COVID-19 (CoronaVIrus Disease). Following the announcement of the first cases and the declaration of...
-
News | 2020.10.22
Coronavirus: Institut Pasteur warns against false information circulating on social media
-ENGLISH VERSION COMING SOON-Mis à jour le 20 mars 2023.En 2020-2021, lorsque la pandémie de Covid-19 était à son pic, de nombreuses informations circulaient dans les médias, sur les réseaux sociaux, les messageries instantanées, etc. Ces messages ont pu parfois contenir des informations erronées ou s’appuyant sur des propos attribués à tort à des chercheurs de l’Institut Pasteur à...
-
News | 2020.04.28
International Network of Pasteur Institutes: deepening the scientific collective strategy
Three years ago, the scientific community of the Institut Pasteur International Network (IPIN) expressed its desire to build a comprehensive strategy in order to strengthen its positioning and establish itself as a global public health authority. The Scientific Steering Committee of the Institut Pasteur International Network(COS-RIIP) was created in August 2019 to help achieve this goal....
-
Article | 2020.08.20
The Carnot Label
Founded in 2006, the Carnot Label, granted by the French government, was designed to develop partnership-based research, meaning research conducted by public laboratories in partnership with socio-economic players, primarily industry (from SMEs to large corporations), to serve their needs.
-
News | 2020.10.15
A Center for Research in Emerging Infectious Diseases, funded by NIH at the Institut Pasteur in Paris
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded 11 grants to establish the Centers for Research in Emerging Infectious Diseases (CREID), including a coordinating center. One of those centers, and the sole center coordinated by a non-American organization, is the Pasteur International Center for Research on Emerging...
-
News | 2021.09.30
An exceptional case of rabies in France transmitted by a bat
On rare occasions in mainland France, a bite or scratch by a bat can transmit a virus capable of causing rabies, as was the case for a patient in 2019. Experts from the National Reference Center for Rabies at the Institut Pasteur contributed to a study on that particular case this year, in cooperation with research teams from the Institut Pasteur and Necker Enfants Malades and Pitié-Salpêtrière...
-
Document de presse | 2022.10.21
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the...